Heparin in plasma samples causes nonspecific binding to histones on Western blots

Journal of Immunological Methods

Volumn 226, Issue 1-2, 1999, Pages 11-18

  Alcantara, Flavio F ^a   Iglehart, Dirk J ^b   Ochs, Robert L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibodies; Artifact; Heparin; Histones; Immunoglobulin aggregates; Plasma

Indexed keywords

CITRATE SODIUM; EDETIC ACID; HEPARIN; HEPARIN LYASE; HISTONE; OXALOACETIC ACID;

ANTIGEN ANTIBODY REACTION; ARTICLE; ARTIFACT; BINDING AFFINITY; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN AGGREGATE; PRIORITY JOURNAL; REPRODUCIBILITY; WESTERN BLOTTING;

ANTICOAGULANTS; BLOTTING, WESTERN; HEPARIN; HISTONES; HUMANS; TUMOR CELLS, CULTURED;

EID: 0032812247     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00043-5     Document Type: Article

References (15)

1. Beutler E., Gelbart T., Kuhl W. Interference of heparin with polymerase chain reaction. Biotechniques. 9:1990;166.
2. Burlingame, R.W., Rubin, R.L., 1994. Manual of biological markers of disease. In: Venrooij, W.J., Maini, R.N. (Eds.), Histones. Kluwer Academic Publishers, Dortrecht, The Netherlands, B2.2/1-B2.2/28.
3. Chiller J.M., Weigle W.O. Cellular events during induction of immunologic unresponsiveness in adult mice. J. Immunol. 106:1971;1647.
4. Hallbach J., Hoffman G.E., Guder W.G. Overestimation of albumin in heparinized plasma. Clin. Chem. 37:1991;566.
5. Henry, J.B., 1996. In: Henry, J.B. (Ed.), Clinical Diagnosis and Management By Laboratory Methods. Saunders, Philadelphia, PA, pp. 9 and 14.
6. Hileman R.E., Fromm J.R., Weiler J.M., Linhardt R.J. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays. 20:1998;156.
7. Jung R., Låbcke C., Wagener C., Neumaier M. Reversal of RT-PCR inhibition observed in heparinized clinical specimens. Biotechniques. 23:1997;24.
8. Karon B.S., Kempe K.C., Scott M.G. Heparin interference with sodium and albumin assays. Clin. Chem. 43:1997;697.
9. Lahiri D.K., Davis D., Atkins M., Nurnberger J.I. Jr. Factors that influence radioimmunoassays of human plasma melatonin: a modified column procedure to eliminate interference. Biochem. Med. Metab. Biol. 49:1993;36.
10. Lane, D.A., Lindahl, U., 1989. In: Lane, D.A., Lindahl, U. (Eds.) Heparin: Chemical and Biological Properties Clinical Applications. CRC Press, Boca Raton, FL, pp. 51 and 363.
11. Linhardt R.J., Fitzgerald G.L., Cooney C.L., Langer R. Mode of action of heparin lyase on heparin. Biochem. Biophys. Acta. 702:1982;197-203.
12. Ochs R.L., Stein T.W., Peebles C.L., Gittes R.F., Tan E.M. Autoantibodies in interstitial cystitis. J. Urol. 151:1994;587.
13. Ooi D.S., Perkins S.L., Tokessy N.E. Elimination of fibrinogen interference in a dye-binding method for iron. Clin. Chem. 38:1992;541.
14. Schiltz M.P., Lieber J., Giorno R.C., Claman H.N. Mast cell immunohistochemistry: non-immunological immunostaining mediated by nonspecific F(ab′)2-mast cell secretory granule interaction. Histochem. J. 25:1993;642.
15. Weber J.A., van Zanten A.P. Elimination of heparin interference in the determination of gamma-GT. Clin. Chim. Acta. 169:1987;345.